GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Short-Term Debt

IDRSF (Idorsia) Short-Term Debt : $236.07 Mil (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Idorsia Short-Term Debt?

Idorsia's Short-Term Debt for the quarter that ended in Sep. 2024 was $236.07 Mil.

Idorsia's quarterly Short-Term Debt declined from Mar. 2024 ($224.98 Mil) to Jun. 2024 ($223.75 Mil) but then increased from Jun. 2024 ($223.75 Mil) to Sep. 2024 ($236.07 Mil).

Idorsia's annual Short-Term Debt stayed the same from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($231.09 Mil).

Idorsia Short-Term Debt Historical Data

The historical data trend for Idorsia's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Short-Term Debt Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial - - - - 231.09

Idorsia Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 222.07 231.09 224.98 223.75 236.07

Idorsia Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Idorsia Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Idorsia's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Short-Term Debt
Comparable Companies
XSWX:MOLN XSWX:NWRN XSWX:SANN XSWX:XLS XSWX:BIOV XSWX:RLF XSWX:EVE XSWX:ADXN XSWX:BSLN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270 SMMT
Traded in Other Exchanges
IDIAz:UK 0RQE:UK IDIA:Switzerland
Address
Hegenheimermattweg 91, Allschwil, CHE, 4123
Website
https://www.idorsia.com
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.